Scientific program

• Multimorbidity and the evolving challenge of polypharmacy
• Innovative medicines - opportunities and challenges
• Emerging data capabilities: the opportunities and challenges for DUR
• Antimicrobial Resistance: a One-Health Approach

As well as other familiar drug utilisation topics covering specific therapeutic and patient groups, adherence, intervention and implementation.

Key workshops: appropriate vs inappropriate polypharmacy, policy/practice focus of de-prescribing, DUR in management of new medicines.

PROGRAM AT A GLANCE

Download as pdf >>>